Vaxxinity Faces Nasdaq Delisting Over Share Price
PremiumCompany AnnouncementsVaxxinity Faces Nasdaq Delisting Over Share Price
9M ago
Vaxxinity announces publication of data on VXX-401
Premium
The Fly
Vaxxinity announces publication of data on VXX-401
9M ago
Vaxxinity announces research collaboration with CTRND
Premium
The Fly
Vaxxinity announces research collaboration with CTRND
10M ago
Vaxxinity announces publication of Phase 2 trial of UB-311
PremiumThe FlyVaxxinity announces publication of Phase 2 trial of UB-311
1y ago
Vaxxinity reports Q2 EPS (11c) vs (14c) last year
Premium
The Fly
Vaxxinity reports Q2 EPS (11c) vs (14c) last year
1y ago
Vaxxinity announces new Phase 1 trial data for UB-312
Premium
The Fly
Vaxxinity announces new Phase 1 trial data for UB-312
1y ago
Vaxxinity announces first subjects dosed in Phase 1 trial of VXX-401
PremiumThe FlyVaxxinity announces first subjects dosed in Phase 1 trial of VXX-401
2y ago
Vaxxinity announces Phase 3 COVID-19 booster data for UB-612
Premium
The Fly
Vaxxinity announces Phase 3 COVID-19 booster data for UB-612
2y ago
Vaxxinity to hold analyst and research and development day
Premium
The Fly
Vaxxinity to hold analyst and research and development day
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100